ARCHIVES

Abraxane and Gemcitabine Improves Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Updates Policy On Large Grants

May 10, 1996

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

DCE Concepts Statements

March 11, 1988